REMUS
Start SIP
Invest Now
Start SIP in REMUS
Performance
- Low
- ₹671
- High
- ₹690
- 52 Week Low
- ₹611
- 52 Week High
- ₹1,145
- Open Price₹690
- Previous Close₹700
- Volume3,400
- 50 DMA₹697.04
- 100 DMA₹733.18
- 200 DMA₹806.95
Investment Returns
- Over 1 Month -4.04%
- Over 3 Month -11.35%
- Over 6 Month -20.2%
- Over 1 Year -32.32%
Smart Investing Starts Here Start SIP with Remus Pharmaceuticals for Steady Growth!
Remus Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 27.5
- PEG Ratio
- -
- Market Cap Cr
- 798
- P/B Ratio
- 2.6
- Average True Range
- 32.54
- EPS
- 24.53
- Dividend Yield
- 0.1
- MACD Signal
- -8.27
- RSI
- 48.16
- MFI
- 58.29
Remus Pharmaceuticals Financials
Remus Pharmaceuticals Technicals
EMA & SMA
Current Price
₹677.50
-22.5
(-3.21%)
- Bearish Moving Average 15
- Bullish Moving Average 1
- 20 Day
- ₹682.87
- 50 Day
- ₹697.04
- 100 Day
- ₹733.18
- 200 Day
- ₹806.95
Resistance and Support
679.5
- R3 707.00
- R2 698.50
- R1 688.00
- S1 669.00
- S2 660.50
- S3 650.00
Remus Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-10 | Quarterly Results & Interim Dividend | |
| 2025-05-17 | Audited Results, Dividend & Others | To consider 1. Bonus 2. Other business matters. Interim Dividend of Rs. 2 per equity share. |
| 2024-11-09 | Quarterly Results & Interim Dividend | To consider other business matters. Interim Dividend of Rs. 2 per equity share. |
| 2024-05-16 | Audited Results | |
| 2024-04-23 | Bonus issue & Interim Dividend |
Remus Pharmaceuticals F&O
About Remus Pharmaceuticals
- NSE Symbol
- REMUS
- BSE Symbol
- Managing Director
- Mr. Arpit Deepakkumar Shah
- ISIN
- INE0O5T01011
Similar Stocks to Remus Pharmaceuticals
Remus Pharmaceuticals FAQs
Remus Pharmaceuticals share price is ₹677 As on 14 February, 2026 | 19:23
The Market Cap of Remus Pharmaceuticals is ₹798.4 Cr As on 14 February, 2026 | 19:23
The P/E ratio of Remus Pharmaceuticals is 27.5 As on 14 February, 2026 | 19:23
The PB ratio of Remus Pharmaceuticals is 2.6 As on 14 February, 2026 | 19:23
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.